Nagaraja SURYADEVARA

Dr. Nagaraja SURYADEVARA


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in International Journal of Pharmacy and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
VVVenkatasthya Sai Appala Raju Velaga
Venkatasthya Sai Appala Raju Velaga
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
LCLim Li Chee
Lim Li Chee
NINahlah Elkudssiah Ismail
Nahlah Elkudssiah Ismail
Objective: This study evaluates the anti-inflammatory activities of different solvent extracts of Moringa oleifera flowers using carrageenan-induced mice paw edema.Methods: Soxhlet extraction method was employed in this study to extract the crude phytochemicals. Phytochemical analysis testing of Moringa oleifera extracts was performed to identify the presence of various phytoconstituents based on the standard procedures. The anti-inflammatory activity was evaluated using acute inflammatory model carrageenan-induced paw edema. Three different flower extracts (petroleum ether, chloroform and methanol) of Moringa oleifera at the dose level of 500 mg/kg body weight. The anti-inflammatory activity on the different extracts of Moringa oleifera was determined through the α-carrageenan induced left hind paw oedema method in albino mice. 0.05 ml of 1% w/v carrageenan suspension was reconstituted with normal saline (0.9% NaCl) to give a homogenous solution which then be injected into the subplantar tissue of the left hind paw of each mice to induce acute inflammation.Results: Treatment with three different solvent extracts showed significant (p

1 January 2020 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
GDGokila Devi
Gokila Devi
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
DIDivyabharathi
Divyabharathi
GOGopinath
Gopinath
LVL. R. Venkatasathya Sai Appala Raju Velaga
L. R. Venkatasathya Sai Appala Raju Velaga
PPP. Ponmurugan
P. Ponmurugan
The present work was conducted to study the effective solvents for extracting therapeutic compounds from M. oleifera using GC-MS. In this process the M. oleifera leaf, pod and bark were collected, air dried and powdered and crude extracts were isolated using methanol, ethanol, acetone, petroleum ether, ethyl acetate and water. Phytochemical tests for alkaloids, saponins, protein, flavonoids, carbohydrates, tannins, terpenoids, phenols, glycosides and phytosteroids showed presence in all the components of leaf, pod and bark in one or the other tests. However, the extraction was better in petroleum ether, acetone, ethanol and methanol. The GC-MS analysis of the extracts like Methanol, Ethanol and Acetone showed six common compounds with antimicrobial activity. Antibiotic sensitivity of pathogenic microbes V. cholera, Salmonella sp., E. coli, Klebsiella sp., Pseudomonas sp. against Gentamycin, Streptomycin, Erythromycin, Tetracycline, Kanamycin, Nalidixic acid, Ciproflaxacin, Neomycin and Rifampicin was performed. V. cholera was resistant to Nalidixic acid, Salmonella sp. was not resistant to any of the antibiotics used, E. coli was resistant to Streptomycin, Kanamycin and Ciproflaxacin, Klebsiella was resistant to Nalidixic acid, Pseudomonas was resistant to streptomycin and Rifampicin. Leaf extract with methanol solvent showed highest antibacterial activity greater than the antibiotics used followed by ethanol extract however, acetone extract showed antibacterial activity only for Klebsiella sp. This shows that M. oleifera not only shows antimicrobial activity it also varies with the solvent.

1 November 2024 in Current Trends in Biotechnology and Pharmacy
Verified
Journal Article
Open access
PDF file
LMLishaleni Mohan
Lishaleni Mohan
MAMohomed Faizal Umair Ahamed
Mohomed Faizal Umair Ahamed
CVCharles Arvind Sethuraman Vairavan
Charles Arvind Sethuraman Vairavan
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
The BCL (B-cell lymphoma) protein family is a diverse group of regulators critically involved in apoptosis, a tightly controlled process crucial for maintaining tissue homeostasis. Dysregulation of apoptosis is a common feature in cancer, emphasizing the need to comprehend the intricate mechanisms underlying the function of the BCL family. This literature review offers a comprehensive exploration of the structural domain organization of the BCL family, shedding light on how these proteins orchestrate apoptosis. The family comprises anti-apoptotic proteins, pro-apoptotic effectors, and BH3(BCL- 2 homology 3)-only proteins, each with distinct structural features and functional roles in apoptotic signaling pathways. Anti-apoptotic proteins like BCL-2 serve as guardians against cell death by preserving mitochondrial integrity. Pro-apoptotic effectors, on the other hand, actively promote apoptosis by inducing mitochondrial outer membrane permeabilization. BH3-only proteins act as molecular switches, mediating the delicate balance between proand anti-apoptotic signals. This review delves into the specific role of BCL-2, a prominent family member, in various cancers such as lung, breast, and prostate cancers. Highlighting its significance as a potential therapeutic target, the article underscores the importance of understanding the molecular nuances of BCL-2 in cancer progression. Moreover, recent advancements in BCL-2 inhibitor development are discussed, showcasing their potential as targeted therapies for cancer treatment. These inhibitors represent a promising avenue for personalized cancer therapy, aiming to selectively induce apoptosis in cancer cells while sparing normal cells. The review emphasizes the importance of these inhibitors in addressing the specific challenges posed by BCL-2 dysregulation in diverse cancer types. By elucidating the structural and functional aspects of the BCL protein family, this literature review provides valuable insights into apoptotic signaling pathways. It not only deepens our understanding of the molecular intricacies governing cell death but also presents novel strategies to modulate apoptosis in cancer cells. Ultimately, the article highlights the significance of BCL proteins as promising therapeutic targets and the potential of BCL-2 inhibitors for personalized cancer therapy, paving the way for advancements in cancer treatment.

1 January 2020 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
VVVenkatasathya Sai Appala Raju Velaga
Venkatasathya Sai Appala Raju Velaga
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
RYRicca Tai Ching Ying
Ricca Tai Ching Ying
PPP Ponmurugan
P Ponmurugan
GDGokila Devi
Gokila Devi

30 December 2019 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
YKYoke Ing Kwan
Yoke Ing Kwan
GSGnanendra Shanmugam
Gnanendra Shanmugam
PPPonmurugan P
Ponmurugan P
BGBalavinayagamani Ganapathy
Balavinayagamani Ganapathy
VVVenkatasathya Sai Appala Raju Velaga
Venkatasathya Sai Appala Raju Velaga

30 August 2017 in Asian Pacific Journal of Cancer Biology
Verified
Journal Article
Open access
PDF file
GTGokila Devi T
Gokila Devi T
NSNagaraja SURYADEVARA
Nagaraja SURYADEVARA
GRGopinath L R
Gopinath L R
Objective: The present study determines the potent cytotoxic and antitumor properties of methanolic extract of Moringa oleifera leaves.Material and Method: The leaves were collected from in and around Tiruchengode of Nammakal district of Tamilnadu. The collected leaves were shade dried and powdered and the Methanolic extract was extracted using the soxhlet apparatus. In-vitro cytotoxicity study was done by Tryphan Blue Dye Exclusion method and MTT (3-(4, 5-dimethyl thiazolyl-2)-2, 5- diphenyltetrazolium bromide) assay. In short-term cytotoxicity study by Tryphan Blue Dye Exclusion method the IC50 value against EAC cell lines was found to be 163.91 µg/ml. In Long-term cytotoxicity study by MTT assay the IC50 value against Normal Mouse Embryonic Fibroblast (NIH 3T3) was found to be 260.85 µg/ml for Human Cervical Cancer cells (HeLA) was 182.41 µg/ml for Human Laryngeal Epithelial Carcinoma (HeP-2) was 195.93. µg/ml and for Human Liver Cancer cells (HepG2) was 168.61 µg/ml. The MST of the control group was 17.33 ± 1.53 days, whereas it was 43.67 ± 1.15, 23.67 ± 1.53 and 33.33 ± 1.53 days for the groups treated with MMO (200 and 400mg/kg) and 5 FU respectively (0.001 & 0.001). The increase in lifespan of Tumour-bearing mice treated with MMO and 5-FU was found to be 36. 75, 92.78 and 152.84 respectively.Result: Haematological parameters of a tumour bearing mice on the day 14 were showed significant changes when compared to normal mice. The total WBC count, protein and PCV were found to increase with a reduction in the hemoglobin content of RBC. At the same time interval, MMO (200 and 400mg/kg) treatment could change these parameters near normal. Maximum alternation occurred in the MMO treatment at the dose of (400mg/kg). There was the significant reduction in the Tumour volume of mice treated with MMO (200 and 400 mg/kg/p.o.). The Tumour volume of control animals was 2. 92 ± 0.12 ml where it was 2.55 ± 0.11 ml and 1.82 ± 0.04 ml for the groups treated with MMO (200 and 400mg/kg/p.o) respectively (P < 0.01 & 0.005).Coclusion: The present study provides clear evidence, that the extract of Moringa olifera shows effective cytotoxicity against Ehrlich ascites carcinoma (EAC) cells in Swiss albino mice. A further study about the active principles and mechanism of action of the Methanolic extract of Moringa oleifera at the molecular level was needed.